Quanterix Corporation (QTRX)
NASDAQ: QTRX · Real-Time Price · USD
5.59
+0.73 (15.02%)
At close: Apr 9, 2025, 4:00 PM
5.55
-0.04 (-0.72%)
Pre-market: Apr 10, 2025, 8:43 AM EDT
Quanterix Revenue
In the year 2024, Quanterix had annual revenue of $137.42M with 12.30% growth. Quanterix had revenue of $35.16M in the quarter ending December 31, 2024, with 11.45% growth.
Revenue (ttm)
$137.42M
Revenue Growth
+12.30%
P/S Ratio
1.56
Revenue / Employee
$291,764
Employees
471
Market Cap
216.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 137.42M | 15.05M | 12.30% |
Dec 31, 2023 | 122.37M | 16.85M | 15.96% |
Dec 31, 2022 | 105.52M | -5.03M | -4.55% |
Dec 31, 2021 | 110.56M | 24.18M | 27.99% |
Dec 31, 2020 | 86.38M | 29.64M | 52.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
QTRX News
- 3 days ago - Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya - Business Wire
- 9 days ago - Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit - Business Wire
- 17 days ago - Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences - Business Wire
- 23 days ago - Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Quanterix Releases Financial Results for the Fourth Quarter of 2024 - Business Wire
- 23 days ago - Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call - Business Wire
- 27 days ago - Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 - Business Wire
- 4 weeks ago - Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences - Business Wire